These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20393750)

  • 21. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy.
    Seeman T; Gilík J; Vondrák K; Simková E; Flögelová H; Hladíková M; Janda J
    Am J Hypertens; 2007 Sep; 20(9):990-6. PubMed ID: 17765141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
    Pouleur AC; Uno H; Prescott MF; Desai A; Appelbaum E; Lukashevich V; Smith BA; Dahlöf B; Solomon SD;
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):483-90. PubMed ID: 21746765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.
    Dahlof B; Zanchetti A; Diez J; Nicholls MG; Yu CM; Barrios V; Aurup P; Smith RD; Johansson M;
    J Hypertens; 2002 Sep; 20(9):1855-64. PubMed ID: 12195129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
    Pierdomenico SD; Lapenna D; Cuccurullo F
    Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired left ventricular synchronicity in hypertensive patients with ventricular hypertrophy.
    Tan HW; Zheng GL; Li L; Wang ZH; Gong HP; Zhang Y; Zhong M; Zhang W
    J Hypertens; 2008 Mar; 26(3):553-9. PubMed ID: 18300868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients.
    Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ
    Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
    Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy.
    Kucukler N; Kurt IH; Topaloglu C; Gurbuz S; Yalcin F
    J Cardiovasc Med (Hagerstown); 2012 Mar; 13(3):181-6. PubMed ID: 22306782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure profile in renal transplant recipients and its relation to diastolic function: tissue Doppler echocardiographic study.
    Basiratnia M; Esteghamati M; Ajami GH; Amoozgar H; Cheriki C; Soltani M; Derakhshan A; Fallahzadeh MH
    Pediatr Nephrol; 2011 Mar; 26(3):449-57. PubMed ID: 21203779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of antihypertensive therapy on blood pressure and left ventricular hypertrophy in patients with severe hypertension.
    Sumino H; Nakamura T; Kanda T; Sakamaki T; Sato K; Saito Y; Hoshino J; Kurashina T; Ono Z; Takahashi T; Ichikawa S; Kurabayashi M; Nagai R
    Jpn Heart J; 2000 May; 41(3):339-48. PubMed ID: 10987352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician?
    Cuspidi C; Esposito A; Negri F; Sala C; Masaidi M; Giudici V; Zanchetti A; Mancia G
    Am J Hypertens; 2008 Apr; 21(4):458-63. PubMed ID: 18369363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy.
    Yasunari K; Maeda K; Watanabe T; Nakamura M; Yoshikawa J; Asada A
    J Am Coll Cardiol; 2004 Jun; 43(11):2116-23. PubMed ID: 15172423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of blood pressure control on prevalence of left ventricular hypertrophy in treated hypertensive patients.
    Cuspidi C; Lonati L; Sampieri L; Macca G; Michev I; Salerno M; Fusi V; Leonetti G; Zanchetti A
    Cardiology; 2000; 93(3):149-54. PubMed ID: 10965085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients].
    Ito O; Okamoto M; Murakami Y; Nakayama R
    J Cardiol; 1991; 21(4):931-41. PubMed ID: 1844449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.
    Rodilla E; Pascual JM; Costa JA; Martin J; Gonzalez C; Redon J
    J Hypertens; 2013 Aug; 31(8):1683-91. PubMed ID: 23835910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
    Thürmann PA; Kenedi P; Schmidt A; Harder S; Rietbrock N
    Circulation; 1998 Nov; 98(19):2037-42. PubMed ID: 9808602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.